60 Degrees Pharmaceuticals Warrant
SXTPW
5 hedge funds and large institutions have $24.3K invested in 60 Degrees Pharmaceuticals Warrant in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 2 reducing their positions, and 2 closing their positions.
121% more capital invested
Capital invested by funds: $11K → $24.3K (+$13.3K)
3.86% more ownership
Funds ownership: 25.74% → 29.61% (+3.9%)
17% less funds holding
Funds holding: 6 → 5 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$77 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$1.28K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$348 |
| 3 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$115 |
| 4 |
CS
Clear Street
New York
|
-$10 |
SXTPW Hedge Fund Activity: Q2 2025 in Review
5 of the 7,613 institutional investors tracked by Wall St. Rank reported a position in 60 Degrees Pharmaceuticals Warrant (SXTPW) for Q2 2025, worth a combined $24.3K — up 121% from $11K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of SXTPW and 1 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 0 added.
The largest buyer was UBS Group, opening a new position worth an estimated $77. The largest seller was Citadel Advisors, cutting an estimated $1.28K.
- 5 institutional investors held 60 Degrees Pharmaceuticals Warrant (SXTPW) as of Q2 2025, down from 6 in Q1 2025.
- Funds reported $24.3K of 60 Degrees Pharmaceuticals Warrant stock for Q2 2025, up 121% quarter-over-quarter.
- 1 fund opened new 60 Degrees Pharmaceuticals Warrant positions in Q2 2025 and 2 closed out, a net change of -1 holder.
- The largest 60 Degrees Pharmaceuticals Warrant buyer in Q2 2025 was UBS Group, an estimated $77 added.
- The largest 60 Degrees Pharmaceuticals Warrant seller in Q2 2025 was Citadel Advisors, an estimated $1.28K sold.
Based on aggregated 13F filings for Q2 2025.